Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ping An Biomedical (PASW) Accounts Payables (2024 - 2025)

Ping An Biomedical filings provide 2 years of Accounts Payables readings, the most recent being $1.3 million for Q3 2025.

  • On a quarterly basis, Accounts Payables rose 1450.46% to $1.3 million in Q3 2025 year-over-year; TTM through Sep 2025 was $1.3 million, a 1450.46% increase, with the full-year FY2025 number at $40409.0, down 52.36% from a year prior.
  • Accounts Payables hit $1.3 million in Q3 2025 for Ping An Biomedical, up from $84827.7 in the prior quarter.
  • In the past five years, Accounts Payables ranged from a high of $1.3 million in Q3 2025 to a low of $84827.7 in Q3 2024.